IDH2 and glioblastoma: Among cases of astrocytoma, 35 (39.7%) were graded as grade II, 26 (29.5%) as grade III, and 27 (30.6%) as grade IV (IDH-mutant glioblastoma) at the time of diagnosis according to WHO CNS 2016.